NCT03950882View on ClinicalTrials.gov

A Study to Assess the Pharmacokinetics of PXL770 After 4 Weeks of Treatment in Subjects With NAFLD

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

March 29, 2020

Study Completion Date

March 31, 2020

Conditions
Nonalcoholic Fatty Liver
Interventions
DRUG

PXL770

Oral capsule

DRUG

Placebo

Oral capsule

Trial Locations (1)

27265

High Point Clinical Trials Center, High Point

Sponsors

Lead Sponsor

Poxel SA
All Listed Sponsors
lead

Poxel SA

INDUSTRY

NCT03950882 - A Study to Assess the Pharmacokinetics of PXL770 After 4 Weeks of Treatment in Subjects With NAFLD | Biotech Hunter | Biotech Hunter